Jane Street Group LLC Has $284,000 Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Jane Street Group LLC lowered its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 72.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,265 shares of the company's stock after selling 6,008 shares during the quarter. Jane Street Group LLC's holdings in Addus HomeCare were worth $284,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in ADUS. Barclays PLC raised its stake in Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company's stock worth $5,783,000 after acquiring an additional 29,207 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in Addus HomeCare by 0.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock valued at $1,340,000 after purchasing an additional 91 shares during the last quarter. KBC Group NV boosted its position in Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company's stock valued at $102,000 after buying an additional 268 shares in the last quarter. Empowered Funds LLC grew its stake in Addus HomeCare by 31.3% during the fourth quarter. Empowered Funds LLC now owns 18,227 shares of the company's stock worth $2,285,000 after buying an additional 4,340 shares during the last quarter. Finally, Equitable Trust Co. increased its holdings in shares of Addus HomeCare by 47.1% during the fourth quarter. Equitable Trust Co. now owns 7,096 shares of the company's stock worth $889,000 after buying an additional 2,271 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the transaction, the executive vice president now owns 7,796 shares of the company's stock, valued at $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 4.60% of the company's stock.

Addus HomeCare Trading Up 0.2%

Shares of ADUS traded up $0.19 on Friday, reaching $112.35. 30,611 shares of the company's stock were exchanged, compared to its average volume of 168,968. The business has a 50 day moving average price of $105.61 and a two-hundred day moving average price of $112.56. Addus HomeCare Co. has a 12 month low of $88.96 and a 12 month high of $136.72. The stock has a market capitalization of $2.07 billion, a P/E ratio of 25.71, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. During the same quarter in the previous year, the company posted $1.21 EPS. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. Equities research analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Stephens reissued an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie boosted their price objective on Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Wall Street Zen lowered Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. One analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.